tiprankstipranks
Viridian Therapeutics (VRDN)
NASDAQ:VRDN
VRDN
Viridian Therapeutics
RESEARCH TOOLSreports

Viridian Therapeutics (VRDN) Revenue

1,496 Followers
StatisticsMarket CapRevenue

Viridian Therapeutics Revenue

Viridian Therapeutics had a revenue of 132.00K in the quarter ending Dec 31, 2025, with -99.81%. This bring the company's revenue in the last twelve months to 70.85M, Decreased 0.08%. In the fiscal year ending Dec 31, 2025, Viridian Therapeutics had annual revenue of 70.85M with 23359.93% growth.
Revenue (ttm)
70.85M
Revenue Growth
23340.07%
P/S Ratio
20.87
Revenue/Employee
$495,448
Employees
143
Market Cap
$1.48B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
70.85M70.55M+23,359.93%
Dec 31, 2024
302.00K-12.00K-3.82%
Dec 31, 2023
314.00K-1.46M-82.28%
Dec 31, 2022
1.77M-1.19M-40.20%
Dec 31, 2021
2.96M1.91M+182.19%
Dec 31, 2020
1.05M-3.41M-76.46%
Dec 31, 2019
4.46M-3.92M-46.80%
Dec 31, 2018
8.39M4.38M+109.49%
Dec 31, 2017
4.00M――